iodixanol has been researched along with Thrombosis in 11 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The nonionic CM iohexol triggers platelet beta-thromboglobulin (beta-TG) secretion, and thus may activate the platelets and promote thrombosis." | 7.70 | Iohexol, platelet activation and thrombosis. II. Iohexol-induced platelet secretion does not affect collagen-induced or tissue-factor-induced thrombus formation in blood that is anticoagulated with heparin and aspirin. ( Buchmann, M; Hamers, MJ; Sakariassen, KS; Stormorken, H, 1998) |
| "Ioxaglate and iodixanol were virtually inert." | 5.30 | Iohexol, platelet activation and thrombosis. I. Iohexol-induced platelet secretion does not affect thrombus formation in native blood. ( Barstad, RM; Hamers, MJ; Sakariassen, KS; Stormorken, H, 1998) |
| " The nonionic CM iohexol triggers platelet beta-thromboglobulin (beta-TG) secretion, and thus may activate the platelets and promote thrombosis." | 3.70 | Iohexol, platelet activation and thrombosis. II. Iohexol-induced platelet secretion does not affect collagen-induced or tissue-factor-induced thrombus formation in blood that is anticoagulated with heparin and aspirin. ( Buchmann, M; Hamers, MJ; Sakariassen, KS; Stormorken, H, 1998) |
| "Both iopamidol and iodixanol treatments deceased cell viability and increased apoptosis of HUVEC and H5V cells, along with downregulated NOS and ABCG1." | 1.46 | Hypotonic contrast media is more toxic than isotonic contrast media on endothelial cells in vivo and in vitro. ( Liu, Y; Lv, S; Ren, L; Wang, P; Wang, Z, 2017) |
| "Although thrombus can occasionally be difficult to diagnose using structural criteria alone, it can be distinguished from other structures according to tissue characteristics." | 1.34 | Clinical utility of delayed-contrast computed tomography for tissue characterization of cardiac thrombus. ( Cham, MD; Kim, RJ; Krauser, DG; Min, JK; Tortolani, AJ; Weinsaft, JW; Yang, XJ, 2007) |
| "Thrombosis was measured over a blood exposure period of 2 hours by gamma camera imaging of 111In-platelets and by gamma counting of deposited 125I-fibrin." | 1.31 | Antithrombotic effects of ionic and non-ionic contrast media in nonhuman primates. ( Chronos, NA; Hanson, SR; Markou, CP, 2001) |
| "Ioxaglate and iodixanol were virtually inert." | 1.30 | Iohexol, platelet activation and thrombosis. I. Iohexol-induced platelet secretion does not affect thrombus formation in native blood. ( Barstad, RM; Hamers, MJ; Sakariassen, KS; Stormorken, H, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ren, L | 1 |
| Wang, P | 1 |
| Wang, Z | 1 |
| Liu, Y | 1 |
| Lv, S | 1 |
| Shah, B | 1 |
| Berger, JS | 1 |
| Allen, N | 1 |
| Guo, Y | 1 |
| Sedlis, SP | 1 |
| Xu, J | 1 |
| Perez, A | 1 |
| Attubato, M | 1 |
| Slater, J | 1 |
| Feit, F | 1 |
| Seto, AH | 1 |
| Kern, MJ | 1 |
| Krauser, DG | 1 |
| Cham, MD | 1 |
| Tortolani, AJ | 1 |
| Kim, RJ | 1 |
| Yang, XJ | 1 |
| Min, JK | 1 |
| Weinsaft, JW | 1 |
| Jones, CI | 1 |
| Goodall, AH | 1 |
| Le Feuvre, C | 1 |
| Batisse, A | 1 |
| Collet, JP | 1 |
| Batisse, JP | 1 |
| Choussat, R | 1 |
| Beygui, F | 1 |
| Helft, G | 1 |
| Montalescot, G | 1 |
| Metzger, JP | 1 |
| Barstad, RM | 2 |
| Buchmann, MS | 1 |
| Hamers, MJ | 3 |
| Orning, L | 1 |
| Orvim, U | 1 |
| Stormorken, H | 3 |
| Sakariassen, KS | 3 |
| Buchmann, M | 1 |
| Markou, CP | 1 |
| Chronos, NA | 1 |
| Hanson, SR | 1 |
| Schräder, R | 1 |
2 trials available for iodixanol and Thrombosis
| Article | Year |
|---|---|
The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.
Topics: Aged; Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease; Female; Fibrinolysi | 2016 |
Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Clopidogrel; Contrast Media; Coronary Angio | 2006 |
9 other studies available for iodixanol and Thrombosis
| Article | Year |
|---|---|
Hypotonic contrast media is more toxic than isotonic contrast media on endothelial cells in vivo and in vitro.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 1; Biomarkers; Cell Death; Cell Survi | 2017 |
Does the AToMIC trial explode concerns of contrast coagulopathy?
Topics: Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease; Fibrinolysis; Humans; Iox | 2016 |
Clinical utility of delayed-contrast computed tomography for tissue characterization of cardiac thrombus.
Topics: Aged; Contrast Media; Heart Diseases; Humans; Male; Radiographic Image Enhancement; Thrombosis; Time | 2007 |
Differential effects of the iodinated contrast agents Ioxaglate, Iohexol and Iodixanol on thrombus formation and fibrinolysis.
Topics: Blood Platelets; Contrast Media; Dose-Response Relationship, Drug; Fibrinolysis; Humans; Iohexol; Io | 2003 |
Effects of ionic and nonionic contrast media on endothelium and on arterial thrombus formation.
Topics: Angioplasty, Balloon, Coronary; Cells, Cultured; Contrast Media; Endothelium, Vascular; Female; Huma | 1996 |
Iohexol, platelet activation and thrombosis. I. Iohexol-induced platelet secretion does not affect thrombus formation in native blood.
Topics: beta-Thromboglobulin; Blood Donors; Blood Platelets; Collagen; Contrast Media; Dose-Response Relatio | 1998 |
Iohexol, platelet activation and thrombosis. II. Iohexol-induced platelet secretion does not affect collagen-induced or tissue-factor-induced thrombus formation in blood that is anticoagulated with heparin and aspirin.
Topics: Anticoagulants; Aspirin; beta-Thromboglobulin; Blood Platelets; Collagen; Contrast Media; Drug Inter | 1998 |
Antithrombotic effects of ionic and non-ionic contrast media in nonhuman primates.
Topics: Animals; Arteriovenous Shunt, Surgical; Blood Flow Velocity; Contrast Media; Disease Models, Animal; | 2001 |
Ionic or non-ionic contrast media in stent placement.
Topics: Cohort Studies; Contrast Media; Coronary Angiography; Heart Diseases; Humans; Ioxaglic Acid; Stents; | 2001 |